Skip to Content
Opening Bell

Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

1MPast Month3MPast 3 Months6MPast 6 MonthsYTDYear to Date1YPast Year5YPast 5 Years
Selected6M Return
  • AKROAkero Therapeutics Inc—
  • BIAFbioAffinity Technologies Inc− 2.12%
  • PFEPfizer Inc+ 4.98%

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

BIAF− 2.1%PFE+ 5.0%Tap or hover the chart for values along the way
MetricAKROBIAFPFE
Return
Last Price—15.2728.44
Daily Change—+ 19.48%− 1.28%
Period ReturnPast 6 Months—
− 2.12%
+ 4.98%
Valuation
Market Cap$4.50 B$3.24 M$162 B
P/E Ratio——37.65
Dividend Yield——5.38%
Net MarginTrailing 12M—257.3%6.8%
Risk
Beta—-1.360.28
52-Week Range—4.56 — $202.5023.58 — $29.21

Company

  • AKROBiotechnology
  • BIAFBiotechnology
  • PFEHealth Care · Pharmaceuticals

Metrics could not be loaded for AKRO: P/E, dividend, beta and the 52-week range stay empty in that column.

FinnhubUpdated 23:00

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.